###begin article-title 0
###xml 25 27 21 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 89 92 <span type="species:ncbi:10116">Rat</span>
Pivotal Role of the alpha2A-Adrenoceptor in Producing Inflammation and Organ Injury in a Rat Model of Sepsis
###end article-title 0
###begin p 1
Conceived and designed the experiments: RW SMG TSR PW. Performed the experiments: PD MZ WD YJ. Analyzed the data: MM PD MZ RW. Wrote the paper: MM PW.
###end p 1
###begin p 2
Current address: Department of Microbiology & Immunology, CUNY Medical School/Sophie Davis School of Biomedical Education, The City College of New York, New York, New York, United States of America
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 493 494 485 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 547 548 535 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 573 575 557 559 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 582 584 562 564 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 593 595 569 571 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2C</sub>
###xml 722 724 690 692 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 386 390 <span type="species:ncbi:10116">rats</span>
Norepinephrine (NE) modulates the responsiveness of macrophages to proinflammatory stimuli through the activation of adrenergic receptors (ARs). Being part of the stress response, early increases of NE in sepsis sustain adverse systemic inflammatory responses. The intestine is an important source of NE release in the early stage of cecal ligation and puncture (CLP)-induced sepsis in rats, which then stimulates TNF-alpha production in Kupffer cells (KCs) through the activation of the alpha2-AR. It is important to know which of the three alpha2-AR subtypes (i.e., alpha2A, alpha2B or alpha2C) is responsible for the upregulation of TNF-alpha production. The aim of this study was to determine the contribution of alpha2A-AR in this process.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 87 89 83 85 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 223 225 215 217 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 377 379 365 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 504 506 488 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 659 661 635 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 907 909 867 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1010 1012 962 964 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 11 15 <span type="species:ncbi:10116">rats</span>
Adult male rats underwent CLP and KCs were isolated 2 h later. Gene expression of alpha2A-AR was determined. In additional experiments, cultured KCs were incubated with NE with or without BRL-44408 maleate, a specific alpha2A-AR antagonist, and intraportal infusion of NE for 2 h with or without BRL-44408 maleate was carried out in normal animals. Finally, the impact of alpha2A-AR activation by NE was investigated under inflammatory conditions (i.e., endotoxemia and CLP). Gene expression of the alpha2A-AR subtype was significantly upregulated after CLP. NE increased the release of TNF-alpha in cultured KCs, which was specifically inhibited by the alpha2A-AR antagonist BRL-44408. Equally, intraportal NE infusion increased TNF-alpha gene expression in KCs and plasma TNF-alpha which was also abrogated by co-administration of BRL-44408. NE also potentiated LPS-induced TNF-alpha release via the alpha2A-AR in vitro and in vivo. This potentiation of TNF-alpha release by NE was mediated through the alpha2A-AR coupled Galphai protein and the activation of the p38 MAP kinase. Treatment of septic animals with BRL-44408 suppressed TNF-alpha, prevented multiple organ injury and significantly improved survival from 45% to 75%.
###end p 6
###begin title 7
Conclusions/Significance
###end title 7
###begin p 8
###xml 54 55 50 51 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 130 132 122 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 362 364 350 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Our novel finding is that hyperresponsiveness to alpha2-AR stimulation observed in sepsis is primarily due to an increase in alpha2A-AR expression in KCs. This appears to be in part responsible for the increased proinflammatory response and ensuing organ injury in sepsis. These findings provide important feasibility information for further developing the alpha2A-AR antagonist as a new therapy for sepsis.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 156 159 156 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Angus1">[1]</xref>
###xml 289 292 289 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Oberholzer1">[2]</xref>
###xml 294 297 294 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Beutler1">[3]</xref>
###xml 447 450 443 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wang1">[4]</xref>
###xml 452 455 448 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wang2">[5]</xref>
###xml 460 463 456 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Hahn1">[6]</xref>
###xml 476 482 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 482 485 478 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Kovarik1">[7]</xref>
###xml 775 778 771 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Yang1">[8]</xref>
###xml 909 912 905 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Yang2">[9]</xref>
###xml 1046 1047 1026 1027 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1190 1191 1162 1163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1211 1214 1183 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Yang2">[9]</xref>
###xml 1433 1437 1402 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Elenkov1">[10]</xref>
###xml 1444 1445 1409 1410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1660 1664 1625 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Bylund1">[11]</xref>
###xml 1718 1719 1679 1680 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1744 1746 1701 1703 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1753 1755 1706 1708 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1764 1766 1713 1715 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2C</sub>
###xml 1903 1905 1844 1846 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Sepsis and septic shock are complications and considered to be major causes of morbidity and mortality in patients with severe trauma, burns, or blood loss [1]. Tissue-fixed macrophages such as the hepatic Kupffer cells (KCs) are involved in inflammatory and metabolic responses to sepsis [2], [3]. The impairment of hepatocellular function observed in early sepsis appears to be due to upregulation of proinflammatory cytokines such as TNF-alpha [4], [5]. We [6] and Kovarik et al.[7] reported that systemic levels of norepinephrine (NE) increased significantly after the onset of sepsis, induced by cecal ligation and puncture (CLP). Enterectomy prior to the onset of sepsis markedly reduced circulating levels of NE, showing that the gut is a major source of NE in sepsis [8]. The catecholamines NE and epinephrine mediate their physiological responses through a group of adrenergic receptor (AR) subtypes [9]. Studies have suggested that NE at concentrations similar to that found in septic animals (approximately20 nM) mainly stimulate alpha2-adrenergic receptors (ARs). In our previous studies, we reported that gut-derived NE upregulates TNF-alpha production in KCs through the alpha2-adrenergic pathway [9]. This is a novel finding, since the immunological effect of the sympathetic nerve activity and the adrenal epinephrine was previously considered to be anti-inflammatory through the activation of beta-ARs on leukocytes [10]. alpha2-ARs are G-protein coupled receptors that mediate the central and peripheral actions of the primary sympathetic neurotransmitter, NE and the adrenal hormone epinephrine through the intracellular suppression of cAMP [11]. However, it remains unknown which of the three alpha2-AR subtypes (i.e., alpha2A, alpha2B or alpha2C) is responsible for the upregulation of TNF-alpha production. The aim of this study was therefore to determine the contribution of alpha2A-AR in NE-mediated proinflammatory effects in sepsis.
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
Experimental model of sepsis
###end title 12
###begin p 13
###xml 178 189 178 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum.</italic>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wang3">[12]</xref>
###xml 1027 1030 1027 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wang2">[5]</xref>
###xml 1032 1036 1032 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wichterman1">[13]</xref>
###xml 1038 1042 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Yang3">[14]</xref>
###xml 47 51 <span type="species:ncbi:10116">rats</span>
###xml 99 103 <span type="species:ncbi:10116">rats</span>
Polymicrobial sepsis was induced in adult male rats by cecal ligation and puncture (CLP). Briefly, rats were fasted overnight prior to the induction of sepsis, but allowed water ad libitum. The animals were anesthetized with isoflurane inhalation and a 2-cm ventral midline abdominal incision was made. The cecum was then exposed, ligated just distal to the ileocecal valve to avoid intestinal obstruction, punctured twice with an 18-gauge needle, and returned to the abdominal cavity. The incision was closed in layers and the animals were resuscitated with 3 ml/100 g BW normal saline subcutaneously immediately after CLP [12]. This model of sepsis is associated with an early, hyperdynamic phase (i.e., 2-10 h after CLP; characterized by an increased cardiac output and tissue perfusion, decreased vascular resistance, and hyperglycemia), which is followed by a late, hypodynamic phase (16 h after CLP and later; characterized by reduced cardiac output and tissue perfusion, increased vascular resistance, and hypoglycemia) [5], [13], [14]. Sham-operated animals underwent the same surgical procedure except that the cecum was neither ligated nor punctured. Studies were then conducted at 2 h (early sepsis) and 20 h (late sepsis) after the induction of sepsis. This project was approved by the Animal Care and Use Committee of the Feinstein Institute for Medical Research and following national guidelines for the use of animals in research.
###end p 13
###begin title 14
Isolation of Kupffer cells
###end title 14
###begin p 15
###xml 114 118 114 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wang3">[12]</xref>
###xml 367 369 355 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 376 378 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 573 574 555 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1552 1553 1498 1499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1777 1778 1723 1724 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1808 1809 1754 1755 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 51 55 <span type="species:ncbi:10116">rats</span>
###xml 1021 1027 <span type="species:ncbi:9913">bovine</span>
###xml 1678 1684 <span type="species:ncbi:9913">bovine</span>
Kupffer cells were isolated from normal and septic rats as previously described elsewhere with some modifications [12]. Briefly, under isoflurane anesthesia, following a midline incision the inferior vena cava was cannulated and the portal vein was severed. The liver was immediately perfused in situ with approximately60 ml of Hanks balanced salt solution without Ca2+ and Mg2+ (Cellgro, VA) at 37degreesC at a rate of 15 ml/min. This was followed by perfusion with 120 ml of HBSS containing 0.02% collagenase (Worthington, Lakewood, NJ; Type IV, 180 U/mg) and 100 mM CaCl2 solution at the same perfusion rate. The liver was then removed en bloc, rinsed with approximately25 ml of HBSS, minced in a petridish containing HBSS with collagenase, and incubated for 20 min at 37degreesC to further dissociate the cells. The cell suspension was then passed through a 150-mesh, stainless steel screen into cold Dulbecco modified Eagel medium (DMEM; GIBCO Life Technologies, Carlsbad, CA), containing 10% heat-inactivated fetal bovine serum and centrifuged (50 g for 2 min at 4degreesC) to sediment hepatocytes. The remaining cells in the supernatant were collected by centrifugation (450 g for 10 min at 4degreesC). The cell pellets resuspended in DMEM. After washing twice, cells were centrifuged on a density cushion of Percoll at 1,000 g for 15 min at 4degreesC. The buffy coat containing the KCs fraction was collected. The cells were further washed twice. Cell viability as determined by trypan blue exclusion was more than 95%. The yield was at 8-12x106 KCs/liver with a purity of at least 90%. The isolated KCs were then cultured in DMEM, containing 10% heat-inactivated fetal bovine serum, 10 mM HEPES, 100 U/ml penicillin and 100 g/ml streptomycin at the concentration of 106 cells/ml overnight with 5% CO2 at 37degreesC. KCs were allowed to adhere to the bottom of a 24-well plate (Costar) overnight and unattached cells were removed by gentle washing.
###end p 15
###begin title 16
###xml 19 21 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Assessment of alpha2A-AR mRNA
###end title 16
###begin p 17
###xml 24 26 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 922 924 894 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 1082 1114 1054 1086 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATG ACT CTA CCC ACG GCA AG-3&#8242;</named-content>
###xml 1126 1158 1098 1130 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTG GAA GAT GGT GAT GGG TT-3&#8242;</named-content>
###xml 1179 1181 1147 1149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1198 1230 1166 1198 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CGT GTT CGT GGT GTG TTG GT-3&#8242;</named-content>
###xml 1242 1271 1210 1239 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCA GCC GAC CGC TAT GAG-3&#8242;</named-content>
###xml 322 343 <span type="species:ncbi:11786">murine leukemia virus</span>
###xml 741 744 <span type="species:ncbi:10116">rat</span>
###xml 1040 1043 <span type="species:ncbi:10116">rat</span>
###xml 1170 1173 <span type="species:ncbi:10116">rat</span>
Gene expression of alpha2A-AR was assessed by real-time quantitative PCR (Q-PCR). Total RNA was extracted from KCs of CLP and Sham-operated animals as well as from cultured KCs using Tri-reagent (Molecular Research Center, Cincinnati, OH). Q-PCR was carried out on cDNA samples reverse transcribed from 2 microg RNA using murine leukemia virus reverse transcriptase (Applied Biosystems). Using the QuantiTect SYBR Green PCR kit (Qiagen, Valencia, CA), reactions were carried out in 24 microl final volume containing 2 pmol of forward and reverse primers, 12 microl QuantiTect Master Mix, and 1 microl cDNA. Amplification was performed according to Qiagen's recommendations with an Applied Biosystems 7300 real-time PCR. Expression amount of rat GAPDH mRNA was used for normalization of each sample, and analysis of each specific mRNA was conducted in duplicate. Relative expression of mRNA was calculated by the DeltaDeltaCt-method, and results expressed as fold change with respect to the corresponding experimental control. The following rat primers were used: GAPDH (AF 106860): 5'-ATG ACT CTA CCC ACG GCA AG-3' (forward), 5'-CTG GAA GAT GGT GAT GGG TT-3' (reverse); rat alpha2A-AR (NM_012739), 5'-CGT GTT CGT GGT GTG TTG GT-3' (forward), 5'-GCA GCC GAC CGC TAT GAG-3' (reverse).
###end p 17
###begin title 18
###xml 41 42 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Binding capacity and affinity of KC alpha2-adrenoceptors
###end title 18
###begin p 19
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 138 139 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 378 379 360 361 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 389 393 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wang4">[15]</xref>
###xml 409 412 391 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 418 419 400 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
Freshly isolated KCs (106) from sham and septic animals at 2 h after CLP were incubated with [3H]-yohimbine (a radioactively labeled alpha2-AR antagonist; specific activity 79.2 Ci/mmol; Dupont/NEN; final concentration, 2 to 64 nM in a volume of 200 microl) with or without 10 microM of unlabeled yohimbine for 30 min at 37degreesC in an assay buffer (40 mM Tris-HCl, 10 mM MgCl2, pH 7.5) [15]. The value of Bmax and Kd were determined by Scatchard analysis after logarithmic transformation.
###end p 19
###begin title 20
###xml 52 54 48 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Stimulation of isolated Kupffer cells with the alpha2A-AR subtype inhibitor BRL-44408
###end title 20
###begin p 21
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 285 287 281 283 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 815 822 795 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 101 105 <span type="species:ncbi:9913">calf</span>
###xml 493 496 <span type="species:ncbi:10116">rat</span>
###xml 815 822 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
KCs isolated from normal animals were cultured overnight in DMEM medium with 10% heat inactive fetal calf serum, 100 U/ml penicillin/streptomycin, 100 mM HEPES and 100 U/ml L-glutamine at the concentration of 106 cells/ml. KCs were then stimulated with NE (20 nM) with or without alpha2A-AR specific antagonist BRL-44408 maleate (1 microM, Tocris, UK) for 4 h. The supernatant was then collected and TNF-alpha levels were measured by enzyme-linked immunosorbent assay (ELISA) kit specific for rat TNF-alpha (Pharmingen, San Diego, CA). The assay was carried out according to the instructions provided by the manufacturer. For additional p38 MAP kinase pathway studies, KCs were cultured in DMEM for an 1 h (p38 phosphorylation) or 24 h (TNF-alpha release) with the following treatments: NE (20 nM), LPS (100 ng/ml, E. coli 055:B5; Sigma, St. Louis, MO), and the inhibitors BRL-44408 (1 microM), pertussis toxin (PTX, 100 ng/ml), or SB203580 (10 microM).
###end p 21
###begin title 22
Intraportal administration of NE
###end title 22
###begin p 23
###xml 515 519 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wang5">[16]</xref>
###xml 658 661 638 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Hahn1">[6]</xref>
Following anesthesia with isoflurane, a 3-cm midline incision was performed. The small intestine was exposed and a branch of the superior mesenteric vein was cannulated with a PE-10 catheter. It should be noted that this procedure did not cause any apparent gut ischemia. NE (20 microM in normal saline containing 0.1% ascorbic acid to prevent NE oxidation) or vehicle was infused into the portal vein at a rate of 13 microl/min for 2 h using a Harvard pump. Since portal blood flow is approximately13 ml/min/liver [16], the above rate of NE infusion would be expected to increase the portal NE level to 20 nM, which is similar to that observed during sepsis[6]. A third group also received BRL-44408 maleate (1 mM solution at 13 microl/min), which was first infused into the portal vein for 15 min and then followed by infusion of 20 microM NE in combination with 1 mM BRL-44408 for 2 h at an infusion rate of 13 microl/min. After 2 h blood samples were collected by cardiac puncture and KCs were isolated as described above. In additional groups of NE, NE plus BRL-44408, or vehicle-infused animals, LPS (7.5 mg/kg) was administered through intra-peritoneal injection at 30 min after the onset of 2-h infusion. At the end of the infusion (i.e., 1.5 h after LPS challenge), blood samples were collected for plasma TNF-alpha measurement.
###end p 23
###begin title 24
Determination of TNF-alpha production
###end title 24
###begin p 25
###xml 55 56 55 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 281 285 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wu1">[17]</xref>
###xml 133 136 <span type="species:ncbi:10116">rat</span>
Plasma, supernatant from KC culture, and cellular (5x106 KCs) TNF-alpha levels were determined using an ELISA assay kit specific for rat TNF-alpha (Pharmingen, San Diego, CA). Isolated KCs were also used to determine the TNF-alpha gene expression by RT-PCR as described previously [17].
###end p 25
###begin title 26
Determination of p38 MAP kinase phosphorylation
###end title 26
###begin p 27
###xml 545 551 <span type="species:ncbi:9913">bovine</span>
###xml 654 660 <span type="species:ncbi:9986">rabbit</span>
###xml 803 809 <span type="species:ncbi:9986">rabbit</span>
###xml 1017 1023 <span type="species:ncbi:9986">rabbit</span>
KCs were lysed (10 mM Tris saline, pH 7.5 with 1% Triton-100x, 1 mM EDTA, 1 mM EGTA, 2 mM Na-orthovanadate, 0.2 mM PMSF, 2 microg/ml leupeptin, 2 microg/ml aprotinin), centrifuged at 16,000 g for 10 min, the supernatant was collected, and the protein concentration determined. A total of 10 microg of protein was loaded on a 4-12% Bis-Tris gel (Invitrogen, Carlsbad, CA) and electrophoretically fractionated in a MES SDS running buffer (Invitrogen). The protein was then transferred to a 0.45-microm nitrocellulose membrane, and blocked with 5% bovine serum albumin in 10 mM Tris saline with 0.1% Tween 20, pH 7.6 (TBST). The membrane was incubated with rabbit anti-phosphorylated p38 MAP kinases polyclonal antibodies (1:1000) overnight at 4degreesC, followed by incubation in 1:20,000 HRP-linked anti-rabbit IgG for 1 h at room temperature. To reveal the reaction bands, the membrane was reacted with ECL Western blot detection system and exposed on X-ray film. The same membranes were stripped and re-blotted with rabbit anti-total-p38 MAP kinases (1:500; please note that stripping and re-blotting may have reduced the signals) to determine the ratio of phospho-p38 and total p38. A digital image system was used to determine the density of the bands (Bio-Rad, Hercules, CA).
###end p 27
###begin title 28
###xml 20 24 <span type="species:ncbi:10116">rats</span>
Treatment of septic rats with BRL-44408
###end title 28
###begin p 29
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
###xml 1125 1129 <span type="species:ncbi:10116">rats</span>
Rats underwent CLP as described before, the femoral vein was canulated and connected to a Harvard pump. BRL-44408 (2.5 mg/kg BW) or vehicle was infused for 30 minutes using a Harvard pump. The catheter was tunneled out, and the femoral vein was ligated to stop the bleeding. The animals were allowed to wake up and returned to their cages. 20 h later animals sacrificed and blood collected for the measurement of liver transaminases, creatinine, lactate and TNF-alpha using commercial assay kits (Pointe Scientific). KC TNF-alpha mRNA expression was also assessed using the methods described above. The liver enzymes AST and ALT as well as creatinine and lactate levels were measured in blood serum by using commercial assay kits (Pointe Scientific, Canton, MI). In addition we conducted a 10-day survival study was conducted. 20 animals in each group underwent CLP and received either BRL-44408 (2.5 mg/kg BW bolus iv) or the same volume normal saline (Vehicle). 20 h after CLP, the cecum was removed, which based on our experience normally yields a 10-day survival rate of approximately 50%. In additional groups of normal rats, both the left femoral vein and artery were cannulated with a PE-50 tubing. The femoral vein catheter was connected to a Harvard pump for BRL-44408 (2.5 mg/kg BW) or vehicle infusion as described above. The femoral artery catheter was connected to a blood pressure analyzer (BPA; Digi-Med, Louisville, KY) and mean arterial pressure (MAP) and heart rate were recorded continuously.
###end p 29
###begin title 30
Statistical analysis
###end title 30
###begin p 31
All data that passed the normality test are expressed as mean+/-SE and compared by Student's t-test or analysis of variance (ANOVA) using Student-Newman-Keul's post-hoc analysis. Data that are of percentile based nature or failed the normality test are expressed as mean+/-95% confidence, and compared with ANOVA on Ranks. The binding capacity and affinity was estimated using the Scatchard analysis and curves compared by two-way ANOVA. The survival study was analyzed using the Kaplan-Meyer log-rank test. Differences in values were considered significant if P<0.05. All statistical analysis was performed using either the SigmaStat(R) or PRISM(R) software.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
###xml 24 26 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Upregulation of KC alpha2A-AR expression in CLP-induced sepsis
###end title 33
###begin p 34
###xml 87 95 87 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g001">Figure 1</xref>
###xml 125 127 121 123 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 249 251 241 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 261 263 249 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2C</sub>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
Rats were subjected to sepsis by CLP and KCs were isolated 2 h thereafter. As shown in Figure 1, the gene expression of alpha2A-AR was significantly upregulated by 179% at 2 h post-CLP compared to respective sham-operated animals. In contrast, alpha2B and alpha2C-AR expression did not show any changes after CLP (Data not shown).
###end p 34
###begin title 35
###xml 24 26 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Upregulation of KC alpha2A-AR expression in CLP-induced sepsis.
###end title 35
###begin p 36
###xml 24 26 20 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 217 219 205 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ct</italic>
###xml 384 385 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Gene expression of alpha2A-adrenergic receptor (AR) in Kupffer cells isolated from animals at 2 h after cecal ligation and puncture (CLP) or sham-operation. Relative expression of mRNA was calculated by the DeltaDeltaCt-method, and results expressed as fold change with respect to the housekeeping gene GAPDH. Values (n = 6/group) are presented as mean+/-SE and compared by Student's t-test. *P<0.05 vs. Sham.
###end p 36
###begin title 37
###xml 18 19 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Increased KC alpha2-AR binding capacity and affinity in sepsis
###end title 37
###begin p 38
###xml 38 39 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 166 167 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 202 203 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 240 249 232 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g002">Figure 2A</xref>
###xml 274 275 262 263 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 317 318 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 407 408 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 466 473 450 457 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 466 473 450 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g002"><bold>Fig. 2A</bold></xref>
###xml 611 618 595 602 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 611 618 595 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g002"><bold>Fig. 2B</bold></xref>
###xml 720 721 704 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 757 760 741 744 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 776 777 760 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 801 808 785 792 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 801 808 785 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g002"><bold>Fig. 2B</bold></xref>
###xml 835 836 819 820 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 909 916 893 900 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 909 916 893 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g002"><bold>Fig. 2B</bold></xref>
###xml 1074 1075 1056 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1131 1132 1111 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
To investigate whether increased alpha2-AR expression in sepsis leads to enhanced receptor binding, we incubated KCs isolated from sham-operated or CLP animals with [3H]-yohimbine, a radio-labeled alpha2-specific AR antagonist. As shown in Figure 2A, the binding of KC alpha2-AR was saturated at approximately 30 nM [3H] yohimbine in both sham-operated and CLP animals. However, maximal binding of the alpha2-specific ligand was much higher in KCs from CLP animals (Fig. 2A). Data transformation to a Scatchard plot yielded linear regression lines consistent with a single class of antagonist binding capacity (Fig. 2B). Scatchard analysis revealed a 28% increase in maximal binding capacity with an average 24.3 fmol/106 cells 2 h after CLP compared to a Bmax of 19.0 fmol/106 cells in sham animals (Fig. 2B). Similarly, the average Kd decreased by 64% from 47.6 nM in sham animals to 17.2 nM 2 h after CLP (Fig. 2B), indicating increased affinity in septic animals. In addition, we discovered a 50% reduction in cAMP levels in KCs that decreased from 7.31+/-0.14 pmol/5x106 cells in sham-operated animals to 3.82+/-1.70 pmol/5x106 cells at 2 h after CLP (decreased by 48%, n = 4-5; P<0.05).
###end p 38
###begin title 39
###xml 18 19 14 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Increased KC alpha2-AR binding capacity and affinity in sepsis.
###end title 39
###begin p 40
###xml 16 17 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 72 73 68 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 187 190 183 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 196 197 192 193 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 89 92 <span type="species:ncbi:10116">rat</span>
Changes in alpha2-receptor binding of the radiolabeled specific ligand [3H]-yohimbine in rat Kupffer cells obtained from sham-operated and cecal ligation and puncture (CLP) animals (A). Bmax and Kd were estimated using the the Scatchard analysis (B). The data points represent the average of three different experiments. Best fit analysis and two-way ANOVA showed that curves are different for Sham and CLP (P = 0.0036).
###end p 40
###begin title 41
###xml 66 68 58 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Stimulation with NE increases TNF-alpha release from KCs via alpha2A-ARs
###end title 41
###begin p 42
###xml 213 215 201 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 250 256 238 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3</bold>
###xml 250 256 238 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g003"><bold>Fig. 3</bold></xref>
###xml 366 372 350 356 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3</bold>
###xml 366 372 350 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g003"><bold>Fig. 3</bold></xref>
Isolated KCs were stimulated with NE (20 nM) with or without BRL-44408 maleate (1 microM) for 4 h. While TNF-alpha release increased by 440% after NE-stimulation, its increase was completely suppressed after alpha2A-AR blockade by BRL-44408 maleate (Fig. 3). BRL-44408 alone did not have any measurable effects on TNF-alpha release in the absence of NE-stimulation (Fig. 3).
###end p 42
###begin title 43
###xml 66 68 58 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Stimulation with NE increases TNF-alpha release from KCs via alpha2A-ARs.
###end title 43
###begin p 44
###xml 137 139 125 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Alterations of TNF-alpha after stimulation of isolated KCs with NE (20 nM) with or without BRL-44408 maleate (1 microM), a specific alpha2A-AR antagonist, for 4 h. Percentage values (n = 6/group) are presented as mean+/-95% confidence and compared by ANOVA on Ranks and Student-Newman-Keul's method. *P<0.05 vs. Medium; #P<0.05 vs. NE.
###end p 44
###begin title 45
###xml 35 37 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Portal infusion of NE induces alpha2A-AR-dependent TNF-alpha production in KCs
###end title 45
###begin p 46
###xml 30 32 26 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 354 361 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g004">Fig. 4A</xref>
###xml 627 634 603 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g004">Fig. 4B</xref>
###xml 754 761 722 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g004">Fig. 4C</xref>
###xml 896 902 856 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g004">Fig 4C</xref>
###xml 958 960 914 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
To elucidate whether the alpha2A-AR is also responsible for TNF-alpha upregulation in vivo, we administered NE through the portal vein in normal animals for 2 h and isolated KCs for analysis. TNF-alpha gene expression was upregulated by 4-fold in KCs from animals that were subjected to intraportal infusion of NE as compared to vehicle-treated animals (Fig. 4A). BRL-44408 pretreatment prevented the upregulation of TNF-alpha gene expression. Similarly, TNF-alpha protein levels increased after intraportal infusion of NE by 10-fold and co-administration of NE with BRL-44408 maleate reduced cellular TNF-alpha levels by 47% (Fig. 4B). Serum levels of TNF-alpha also increased after intraportal infusion of NE from 40.2+/-0.8 pg/ml to 55.7+/-5.2 pg/ml (Fig. 4C). BRL-44408 significantly suppressed plasma TNF-alpha levels by 25% to blood TNF-alpha concentrations found in sham operated animals (Fig 4C). These results underline the crucial role of the alpha2A-AR in the proinflammatory response of Kupffer cells after NE-stimulation under in vivo conditions.
###end p 46
###begin title 47
###xml 35 37 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Portal infusion of NE induces alpha2A-AR-dependent TNF-alpha production in KCs.
###end title 47
###begin p 48
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo Alterations in Kupffer cell gene expression (A) and protein levels of TNF-alpha (B) as well as serum TNF-alpha levels (C) after administration of NE, NE combined with BRL-44408 maleate for 2 h through the portal vein. A representative gene and ratio of TNF-alpha and housekeeping gene G3PDH are presented in panel (A). Values (n = 5/group) are presented as mean+/-SE and compared by one-way ANOVA and Student-Newman-Keul's method. *P<0.05 vs. Control; #P<0.05 vs. NE.
###end p 48
###begin title 49
###xml 76 78 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
NE-mediated potentiation of LPS-mediated TNF-alpha release through the alpha2A-AR
###end title 49
###begin p 50
###xml 36 38 32 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 198 200 190 192 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 240 247 232 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g005">Fig. 5A</xref>
###xml 262 269 254 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g005">Fig. 5B</xref>
###xml 407 414 395 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g005">Fig. 5A</xref>
###xml 534 541 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g005">Fig. 5A</xref>
###xml 655 657 631 633 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 744 751 712 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g005">Fig. 5A</xref>
###xml 793 795 757 759 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1069 1076 1025 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g005">Fig. 5B</xref>
###xml 1189 1196 1141 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g005">Fig. 5B</xref>
###xml 1226 1228 1174 1176 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1310 1317 1254 1261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g005">Fig. 5B</xref>
###xml 1392 1394 1328 1330 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
To investigate the role of the alpha2A-AR in NE-mediated potentiation of a proinflammatory response to endotoxin, we studied the response of KCs to NE and LPS in the presence or absence of the alpha2A-specific inhibitor BRL-44408 in vitro (Fig. 5A) and in vivo (Fig. 5B). Cultured KCs were responsive to endotoxin and TNF-alpha levels increased by over 16-fold after stimulation with 100 ng/ml LPS (P<0.05, Fig. 5A). The simultaneous treatment with NE+LPS caused TNF-alpha levels increased by an additional 63% (P<0.05 vs. LPS alone, Fig. 5A), indicating a potentiation of LPS-induced TNF-alpha release from cultured KC. Concurrent inhibition of the alpha2A-AR using BRL-44408 (1 microM) significantly attenuated TNF-alpha release by over 60% (Fig. 5A). To verify the crucial role of the alpha2A-AR in the proinflammatory response to NE in endotoxemia, we measured plasma levels of TNF-alpha after intraperitoneal injection of LPS (7.5 mg/kg) and systemic intravenous administration of NE. LPS alone resulted in a 10-fold increase of TNF-alpha plasma levels after 4 h (Fig. 5B) and the co-administration of NE resulted a marked enhancement in plasma TNF-alpha release by 155-fold (P<0.05; Fig. 5B). Administration of the alpha2A-AR antagonist BRL-44408 completely blocked the LPS/NE-induced TNF-alpha release (Fig. 5B). Thus, NE-mediated potentiation of LPS-induced TNF-alpha release is alpha2A-AR-dependent even after systemic application of NE.
###end p 50
###begin title 51
###xml 76 78 68 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
NE-mediated potentiation of LPS-mediated TNF-alpha release through the alpha2A-AR.
###end title 51
###begin p 52
###xml 96 104 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 109 116 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
BRL-44408 maleate blocks TNF-alpha production in LPS-stimulated KCs after co-incubation with NE in vitro and in vivo. (A) Alterations in TNF-alpha release from cultured KCs 24 h after stimulation with NE (20 nM) and LPS (100 ng/ml), with or without BRL-44408 (BRL, 1 microM). Data are presented as mean+/-SE (n = 8) and compared by one-way ANOVA and Student-Newman-Keuls test. *P<0.05 vs. Control; #P<0.05 vs. LPS alone; daggerP<0.05 vs. NE+LPS. (B) Alterations in plasma levels of TNF-alpha after administration of LPS (7.5 mg/kg, intra-peritoneal) and NE (20 microM NE for 2 h at 13 microl/min), with or without BRL-44408 (2.5 mg/kg BW, intra-portal). Data are presented as mean+/-SE (n = 4-6) and compared by one-way ANOVA and Student-Newman-Keul's method. *P<0.05 vs. Control; #P<0.05 vs. LPS alone; daggerP<0.05 vs. NE+LPS.
###end p 52
###begin title 53
###xml 5 7 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
alpha2A-AR-dependent activation of p38 MAP kinase
###end title 53
###begin p 54
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Triantafilou1">[18]</xref>
###xml 213 215 209 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 326 328 318 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 363 369 355 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;i</sub>
###xml 533 540 517 524 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A</bold>
###xml 533 540 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g006"><bold>Fig. 6A</bold></xref>
###xml 588 590 568 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 599 605 579 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;i</sub>
###xml 1021 1028 997 1004 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 1021 1028 997 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g006"><bold>Fig. 6B</bold></xref>
###xml 1179 1181 1151 1153 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1351 1357 1319 1321 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;i</sub>
###xml 1541 1548 1497 1504 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6C</bold>
###xml 1541 1548 1497 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g006"><bold>Fig. 6C</bold></xref>
###xml 1638 1640 1586 1588 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1653 1659 1601 1603 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;i</sub>
LPS induces the activation of intracellular pathways, including the p38 MAP kinase by its phosphoryation, which plays a crucial role in the proinflammatory response of macrophages [18]. To determine, whether alpha2A-AR activation affects the p38 pathway, we stimulated cultured KCs with NE (20 nM) and blocked either the alpha2A-AR with BRL-44408 or its coupled Galphai-protein with pertussis toxin (PTX). Both BRL-44408 (1 microM) and pertussis toxin (PTX, 100 ng/ml) prevented the NE-induced phosphorylation of the p38 MAP kinase (Fig. 6A). This indicates that NE acts through the alpha2A-AR and Galphai protein to activate the p38 MAP kinase. To verify this effect under inflammatory conditions, we assessed NE-mediated phosphorylation of the p38 MAP kinase in cultured KC at 1 h after stimulation with LPS (100 ng/ml). Either agent by itself induced the phosphorylation of p38 compared to control, however, the combination of NE and LPS showed the strongest activation (over 7-fold induction) of p38 in cultured KCs (Fig. 6B). This indicates that LPS-induced p38-activation can be potentiated by simultaneous NE stimulation. To determine the role of this pathway in the alpha2A-AR-mediated proinflammatory effect of NE, additional experiments were performed to measure TNF-alpha release after NE+LPS stimulation with or without inhibition of the Galphai or the p38 MAP kinase. Both PTX (100 ng/ml) and SB203580 (10 microM; a p38 MAP kinase inhibitor) attenuated the NE-mediated increase in TNF-alpha release by 46% and 55% respectively (Fig. 6C). This study further confirms that NE potentiates LPS-induced TNF-alpha through the alpha2A-AR coupled Galphai protein and the activation of the p38 MAP kinase.
###end p 54
###begin title 55
###xml 68 70 64 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
NE-mediated potentiation of p38 MAP kinase phosphorylation via alpha2A-ARs.
###end title 55
###begin p 56
###xml 1018 1024 1006 1008 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;i</sub>
(A) Alterations in p38 MAP kinase after 1 h culture with NE alone (20 nM), NE+BRL-44408 (BRL, 1 microM), or NE+pertussis toxin (PTX, 100 ng/ml). The relative percentage of phosphorylated p38/total p38 MAP kinase is presented as mean+/-95% confidence (n = 4-6) and compared by ANOVA on Ranks and Student-Newman-Keul's method. The Medium group is considered as 100%. *P<0.05 vs. Medium; #P<0.05 vs. NE alone. Representative gels are presented. (B) Enhanced activation of p38 MAP kinase after 1 h culture with a combination of NE (20 nM) and LPS (100 ng/ml). The relative percentage of phosphorylated p38/total p38 MAP kinase ratio is presented as mean+/-95% confidence (n = 4-6) and compared by ANOVA on Ranks and Student-Newman-Keul's method. Medium group is considered as 100%. *P<0.05 vs. Medium; #P<0.05 vs. LPS alone. Representative gels are also presented. (C) Suppression of TNF-alpha release from cultured KCs after stimulation with NE (20 nM)+LPS (100 ng/ml) with or without pertussistoxin (PTX, 100 ng/ml), a Galphai-protein inhibitor, or SB203580 (10 microM), a p38 MAP kinase inhibitor. Data are presented as mean+/-SE (n = 4-6) and compared by one-way ANOVA and Student-Newman-Keul's method. *P<0.05 vs. Medium; #P<0.05 vs. LPS+NE.
###end p 56
###begin title 57
BRL-44408 is beneficial in experimental sepsis
###end title 57
###begin p 58
###xml 16 24 16 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 29 36 29 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 593 603 589 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figs. 7A&#8211;B</bold>
###xml 593 603 589 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g007"><bold>Figs. 7A&#8211;B</bold></xref>
###xml 681 691 673 683 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figs. 7A&#8211;B</bold>
###xml 681 691 673 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g007"><bold>Figs. 7A&#8211;B</bold></xref>
###xml 900 910 892 902 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figs. 7C&#8211;E</bold>
###xml 900 910 892 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g007"><bold>Figs. 7C&#8211;E</bold></xref>
###xml 1074 1081 1066 1073 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7F</bold>
###xml 1074 1081 1066 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g007"><bold>Fig. 7F</bold></xref>
###xml 1367 1375 1359 1367 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 8</bold>
###xml 1367 1375 1359 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g008"><bold>Figure 8</bold></xref>
###xml 1614 1616 1602 1604 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 1745 1753 1733 1741 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 9</bold>
###xml 1745 1753 1733 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005504-g009"><bold>Figure 9</bold></xref>
###xml 278 282 <span type="species:ncbi:10116">rats</span>
###xml 1244 1248 <span type="species:ncbi:10116">rats</span>
###xml 1727 1731 <span type="species:ncbi:10116">rats</span>
Using the above in vitro and in vivo systems, we were able to show that BRL-44408 can attenuate the proinflammatory effect of NE either alone or in conjunction with LPS. To investigate the beneficial effect of BRL-44408 in sepsis, we used an experimental sepsis model of CLP in rats receiving BRL-44408. 20 h later we measured cytokine levels in KCs, plasma and injury paramers for liver (AST & ALT), kidney (creatinine) and general oxigenation (lactate). As expected, TNF-alpha mRNA levels in KCs as well as plasma levels were increased 20 h after CLP by 6.6-fold and 2.4-fold, respectively (Figs. 7A-B). BRL-44408 treatment completely inhibited TNF-alpha production and release (Figs. 7A-B). Similarly, CLP-induced increases in surrogate markers for liver and kidney injury (AST, ALT and creatinine by 4.8-, 4.1-, and 2.9-fold, respectively) were completely blocked after treatment with BRL-44408 (Figs. 7C-E). Lactate, a marker for tissue perfusion and oxygenation, that was increased by 3-fold after CLP and was significantly suppressed by 37% after BRL-44408 infusion (Fig. 7F). These above results indicate that BRL-44408 confers an anti-inflammatory effect and protects from organ injury and tissue malperfusion in CLP-induced sepsis in rats. To show that these beneficial effects translate into an improved outcome, we conducted a survival study. As shown in Figure 8, CLP and vehicle treatment resulted in a 55% mortality rate over a 10-day period. Treatment with BRL-44408, however, protected over 55% of animals at risk, resulting in an overall survival rate of 75%. To determine the effect of the alpha2A-AR blockade on other organ system, we monitored MAP and heart rates during BRL-44408 administration in normal rats. As shown in Figure 9, intravenously infusion of BRL-44408 at the dose of 2.5 mg/kg BW had no measurable effects on MAP and heart rates.
###end p 58
###begin title 59
###xml 27 29 23 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Beneficial effects of alpha2A-AR inhibition in sepsis.
###end title 59
###begin p 60
###xml 322 329 318 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">methods</xref>
###xml 198 202 <span type="species:ncbi:10116">Rats</span>
(A-B) BRL-44408 mediated suppression of TNF-alpha gene expression in Kupffer cells (A) and plasma concentrations (B) 20 h after CLP. (C-F) BRL-44408 mediated improvement of organ damage parameters. Rats underwent CLP and 20 h later ALT (C), AST (D), creatinine (E) and lactate (F) levels were measured as described in the methods. Values (n = 5/group) are presented as means+/-SE and compared by one-way ANOVA and Student-Newman-Keul's method. *P<0.05 vs. Sham; #P<0.05 vs. CLP+Vehicle.
###end p 60
###begin title 61
###xml 9 11 5 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 63 67 <span type="species:ncbi:10116">rats</span>
The alpha2A-AR inhibitor BRL-44408 improves survival in septic rats.
###end title 61
###begin p 62
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
Rats underwent CLP (n = 20/group) and received either Vehicle treatment or BRL-44408 maleate iv 2.5 mg/kg BW. Cecums were removed 20 h later and animals observed for up to 10 days. *P<0.05 vs. Vehicle, Kaplan-Meyer logrank test.
###end p 62
###begin title 63
###xml 58 62 <span type="species:ncbi:10116">rats</span>
BRL-44408 has no effects on MAP and heart rates in normal rats.
###end title 63
###begin p 64
###xml 16 18 12 14 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 294 295 288 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 107 111 <span type="species:ncbi:10116">rats</span>
###xml 120 124 <span type="species:ncbi:10116">rats</span>
Effects of alpha2A-AR inhibitor BRL-44408 on mean arterial pressure (MAP, A) and heart rates (B) in normal rats. Normal rats received either Vehicle treatment or BRL-44408 maleate iv 2.5 mg/kg BW over a period of 30 min. Data are presented as mean+/-SE (n = 5/group), and compared by Student's t-test. No statistical difference was found.
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 175 176 171 172 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 180 184 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Vizi1">[19]</xref>
###xml 196 201 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 260 261 252 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 344 348 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Kotanidou1">[20]</xref>
###xml 473 474 453 454 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 520 521 496 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 614 618 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Zhou1">[21]</xref>
###xml 641 642 609 610 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 723 730 691 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 745 749 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Spengler1">[22]</xref>
###xml 751 755 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Handy1">[23]</xref>
###xml 863 864 823 824 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 869 873 829 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Bylund1">[11]</xref>
###xml 875 879 835 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Hasko1">[24]</xref>
###xml 914 916 870 872 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Gut-derived NE has been shown to play a critical role in inducing hepatocellular dysfunction in early sepsis, exerting its effect through the non-synaptic, high-affinity alpha2-AR [19]. Kotanidou et al. have shown that urethane, a general anesthetic with alpha2-AR blocking properties, protects against LPS partly by reducing TNF-alpha release [20]. We have previously reported that TNF-alpha secretion from NE stimulated Kupffer cells can be inhibited by the general alpha2-AR inhibitor yohimbine, suggesting that alpha2-ARs on Kupffer cells are particularly responsible for the upregulation of TNF-alpha release [21]. The presence of alpha2-ARs on macrophages has been previously confirmed by receptor binding assays and in situ hybridization [22], [23]. Studies by other groups have shown that TNF-alpha upregulation can be mediated by the stimulation of alpha2-ARs [11], [24]. Here we show that it is the alpha2A-AR that is upregulated in KCs leading to enhanced receptor binding and proinflammatory cytokine release in sepsis.
###end p 66
###begin p 67
###xml 105 109 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Zhou1">[21]</xref>
###xml 169 173 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Koo1">[25]</xref>
###xml 266 273 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 669 671 653 655 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
We have previously shown that TNF-alpha is significantly increased by incubation with NE (20 nM) for 4 h [21]. Since KCs are a major source of proinflammatory cytokines [25], intraportal infusion of NE appears to have a direct measurable effect on TNF-alpha release in vivo. Infusion of NE through the femoral vein may reduce active NE levels reaching the liver compared to direct intraportal injection. Hence, one may expect a diminished proinflammatory response of NE after systemic administration. We have shown however, that even after peripheral intravenous administration of NE, the LPS-induced TNF-alpha increase becomes dramatically potentiated through an alpha2A-AR-dependent pathway, possibly through the involvement of other tissue macrophages.
###end p 67
###begin p 68
###xml 68 69 64 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 76 77 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 125 127 110 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1A</sub>
###xml 134 136 115 117 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1B</sub>
###xml 147 149 124 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1C</sub>
###xml 156 158 129 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 165 167 134 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 178 180 143 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2C</sub>
###xml 189 190 151 152 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 196 197 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 207 208 163 164 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 230 231 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 327 331 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Bergmann1">[26]</xref>
###xml 338 339 287 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 360 308 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 367 368 316 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 435 436 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 475 477 424 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 569 573 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Bergmann1">[26]</xref>
###xml 592 593 537 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 788 790 729 731 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 861 862 802 803 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 918 920 855 857 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 951 953 884 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2C</sub>
###xml 1194 1196 1123 1125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
Adrenergic receptors are subdivided in to three major subtypes alpha1, alpha2, and beta, which are then subdivided into alpha1A, alpha1B, and alpha1C, alpha2A, alpha2B, and alpha2C and beta1, beta2, and beta3. Upon binding of beta2-ARs for example, epinephrine and high doses of NE through increasing intracellular cAMP levels [26]. alpha2-adrenoceptors are Gi- and G0-protein coupled receptors that decrease intracellular cAMP, open K+ channels, and inhibit voltage gated Ca2+ channels, all of which lead to hyperpolarization of neurons and activation of immune cells [26]. In the CNS, alpha2-adrenoceptors are predominantly presynaptic. They regulate the release of neurotransmitters through a negative feedback. Functional studies of the genetic receptor subtypes have linked the alpha2B-adrenoceptor to peripheral vasoconstriction and analgesic effects of N2O (nitrous oxide) and other anesthetic agents. The alpha2A-AR, either alone or with alpha2C-AR co-activation, is involved in the central inhibition of sympathetic activities, modulation of neurotransmitter release, sedation, and anti-epileptic effects. As we have shown here, the pro-inflammatory action of NE, mediated by the alpha2A-receptor subtype expressed on hepatic macrophages (i.e., KCs) can now be added to this list.
###end p 68
###begin p 69
###xml 66 67 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 196 202 188 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 312 313 300 301 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 317 321 305 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Flierl1">[27]</xref>
###xml 384 386 368 370 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 543 547 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Flierl1">[27]</xref>
###xml 693 695 673 675 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 779 781 755 757 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 791 793 763 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2C</sub>
###xml 878 880 846 848 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 954 956 914 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1153 1154 1105 1106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1207 1213 1159 1161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;i</sub>
###xml 1411 1418 1359 1366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1460 1468 1408 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1492 1494 1436 1438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1612 1614 1548 1550 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2B</sub>
###xml 1649 1656 1585 1592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1777 1779 1705 1707 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 2145 2149 2061 2065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Borovikova1">[28]</xref>
###xml 2209 2210 2121 2122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 2313 2317 2221 2225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Wang6">[29]</xref>
###xml 2340 2342 2244 2246 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 2405 2412 2309 2316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2422 2430 2326 2334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
So far, however, we could find only one report regarding the alpha2-AR subtypes responsible for TNF-alpha upregulation in pulmonary inflammation and none in sepsis itself. In their work by Flierl et al., the authors focused on the phagocyte-derived cathecholamines that boost inflammatory responses via the alpha2-AR [27]. Although this report indicated similar increases in the alpha2A-AR subtype in alveolar macrophages and neutrophils after LPS-stimulation, the role of individual subtypes in the proinflammatory response was not addressed [27]. In our study we have assessed the influence of these subtypes in hepatic macrophages, i.e., KCs. We have shown that the gene expression of alpha2A-AR has significantly increased 2 h after CLP, while no significant changes in alpha2B and alpha2C-AR could be observed. Kupffer cells stimulated with NE in combination with the alpha2A-AR inhibitor BRL-44408 maleate reduced TNF-alpha release, while the alpha2B-AR inhibitor imiloxan hydrochloride increased TNF-alpha levels (data not shown). The difference between those two receptor subtypes may lie in the intracellular signaling pathways. While all alpha2-ARs suppress intracellular cAMP levels through its Galphai coupled protein, they also change intracellular calcium and potassium levels to a different degree, which may influence intricate signaling pathways and eventually cellular response. As opposed to in vivo findings that showed no differences, our in vitro results show that alpha2B-AR inhibition is able to inhibit TNF-alpha release from cultured KCs, which is further complicating the role of alpha2B-ARs in the inflammatory response. In vivo, intraportal administration of NE significantly increased serum and Kupffer cell levels of TNF-alpha, and only the alpha2A-AR specific antagonist, BRL-44408 could significantly reduce TNF-alpha plasma levels and Kupffer cell TNF-alpha release. Recent reports show that not only sympathetic mediators, but also the cholinergic pathways modulate the systemic inflammatory response. Thus TNF-alpha release can be reduced by increasing efferent vagus nerve activity and acetylcholine release [28]. In this regard, the nicotinic acetylcholine receptor alpha7 subunit appears to be responsible for the inhibition of macrophage TNF-alpha release by acetylcholine [29]. The role of the alpha2A-AR in the regulation of vagus nerve activity is a possibility in vivo, but our in vitro results indicate that the TNF-alpha suppressive effect of BRL-44408 is independent of a parasympathetic influence. Our present work and others' studies also show that this tremendous activation of the sympathetic and parasympathetic nervous system during sepsis is not only a result of these devastating conditions but also influences of inflammatory responses itself by regulating proinflammatory cytokines via adrenergic and cholinergic receptors.
###end p 69
###begin p 70
###xml 5 7 1 3 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 72 76 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Flugge1">[30]</xref>
###xml 77 81 73 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005504-Willems1">[32]</xref>
###xml 459 461 451 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 264 268 <span type="species:ncbi:10116">rats</span>
alpha2A-ARs also have effects on the cardiovascular and nervous systems [30]-[32]. Since changes in MAP and heart rates reflect the activity of both the cardiovascular and nervous systems, we monitored MAP and heart rates during BRL-44408 administration in normal rats. Our results indicate that intravenously infusion of BRL-44408 at the dose of 2.5 mg/kg BW had no measurable effects on the MAP and heart rate. In this regard, the beneficial effect of alpha2A-AR blockade in sepsis is unlikely due to its direct effects on the cardiovascular and nervous systems.
###end p 70
###begin p 71
###xml 65 66 61 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 141 143 133 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
###xml 373 375 361 363 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2A</sub>
In summary, our results suggest that hyperresponsiveness to alpha2-AR stimulation observed in sepsis is primarily due to an increase in alpha2A-AR expression in KCs. This appears to be in-part responsible for the increased proinflammatory response and ensuing organ injury in sepsis. These findings provide important feasibility information for further developing the alpha2A-AR antagonist as a new therapy for sepsis.
###end p 71
###begin title 72
References
###end title 72
###begin article-title 73
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.
###end article-title 73
###begin article-title 74
Sepsis syndromes: understanding the role of innate and acquired immunity.
###end article-title 74
###begin article-title 75
Sepsis and evolution of the innate immune response.
###end article-title 75
###begin article-title 76
Tumor necrosis factor-alpha produces hepatocellular dysfunction despite normal cardiac output and hepatic microcirculation.
###end article-title 76
###begin article-title 77
Mechanism of hepatocellular dysfunction during hyperdynamic sepsis.
###end article-title 77
###begin article-title 78
Sustained elevation in circulating catecholamine levels during polymicrobial sepsis.
###end article-title 78
###begin article-title 79
###xml 67 70 <span type="species:ncbi:10116">rat</span>
Plasma catecholamines following cecal ligation and puncture in the rat.
###end article-title 79
###begin article-title 80
Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis.
###end article-title 80
###begin article-title 81
Norepinephrine-induced hepatocellular dysfunction in early sepsis is mediated by activation of alpha2-adrenoceptors.
###end article-title 81
###begin article-title 82
The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system.
###end article-title 82
###begin article-title 83
International Union of Pharmacology nomenclature of adrenoceptors.
###end article-title 83
###begin article-title 84
Mechanism of hepatocellular dysfunction during early sepsis: key role of increased gene expression and release of proinflammatory cytokines tumor necrosis factor and interleukin-6.
###end article-title 84
###begin article-title 85
Sepsis and septic shock: a review of laboratory models and a proposal.
###end article-title 85
###begin article-title 86
Differential alterations in systemic and regional oxygen delivery and consumption during the early and late stages of sepsis.
###end article-title 86
###begin article-title 87
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
ATP-MgCl2 administration normalizes macrophage cyclic AMP and beta-adrenergic receptors after hemorrhage and resuscitation.
###end article-title 87
###begin article-title 88
Increase in hepatic blood flow during early sepsis is due to increased portal blood flow.
###end article-title 88
###begin article-title 89
###xml 103 106 <span type="species:ncbi:10116">rat</span>
Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells.
###end article-title 89
###begin article-title 90
Combinational clustering of receptors following stimulation by bacterial products determines lipopolysaccharide responses.
###end article-title 90
###begin article-title 91
Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system.
###end article-title 91
###begin article-title 92
###xml 29 33 <span type="species:ncbi:10116">rats</span>
Urethane anesthesia protects rats against lethal endotoxemia and reduces TNF-alpha release.
###end article-title 92
###begin article-title 93
The role of Kupffer cell alpha(2)-adrenoceptors in norepinephrine-induced TNF-alpha production.
###end article-title 93
###begin article-title 94
Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor.
###end article-title 94
###begin article-title 95
###xml 19 20 15 16 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 72 78 <span type="species:ncbi:9986">rabbit</span>
Expression of alpha2-adrenergic receptors in normal and atherosclerotic rabbit aorta.
###end article-title 95
###begin article-title 96
Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system.
###end article-title 96
###begin article-title 97
Kupffer cells are responsible for producing inflammatory cytokines and hepatocellular dysfunction during early sepsis.
###end article-title 97
###begin article-title 98
Immunomodulatory effects of vasoactive catecholamines.
###end article-title 98
###begin article-title 99
Phagocyte-derived catecholamines enhance acute inflammatory injury.
###end article-title 99
###begin article-title 100
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.
###end article-title 100
###begin article-title 101
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.
###end article-title 101
###begin article-title 102
Alpha2A and alpha2C-adrenoceptor regulation in the brain: alpha2A changes persist after chronic stress.
###end article-title 102
###begin article-title 103
###xml 89 94 <span type="species:ncbi:10090">mouse</span>
In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse prefrontal cortex.
###end article-title 103
###begin article-title 104
The role of several alpha(1)- and alpha(2)-adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation.
###end article-title 104
###begin p 105
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 105
###begin p 106
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was in part supported by National Institutes of Health (NIH) grants R01 GM053008, R01 GM057468 and R01 AG028352 (P. Wang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 106

